nelfinavir has been researched along with Adenovirus Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andriasyan, V; Georgi, F; Greber, UF; Grove, M; Hemmi, S; Kuttler, F; Meili, N; Murer, L; Turcatti, G; Witte, R; Yakimovich, A; Yu, L | 1 |
1 other study(ies) available for nelfinavir and Adenovirus Infections
| Article | Year |
|---|---|
The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.
Topics: Adenoviridae; Adenoviridae Infections; Adenovirus Infections, Human; Adenoviruses, Human; Humans; Nelfinavir; Pharmaceutical Preparations | 2020 |